KCNV2 Antibody (C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q8TDN2 |
---|---|
Clone Names | 100405078 |
Gene ID | 169522 |
---|---|
Other Names | Potassium voltage-gated channel subfamily V member 2, Voltage-gated potassium channel subunit Kv82, KCNV2 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | KCNV2 |
---|---|
Function | Potassium channel subunit. Modulates channel activity by shifting the threshold and the half-maximal activation to more negative values. |
Cellular Location | Cell membrane; Multi-pass membrane protein. Note=Has to be associated with KCNB1 or possibly another partner to get inserted in the plasma membrane. Remains intracellular in the absence of KCNB1 |
Tissue Location | Detected in lung, liver, kidney, pancreas, spleen, thymus, prostate, testis, ovary and colon |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Voltage-gated potassium (Kv) channels represent the mostcomplex class of voltage-gated ion channels from both functionaland structural standpoints. Their diverse functions includeregulating neurotransmitter release, heart rate, insulin secretion,neuronal excitability, epithelial electrolyte transport, smoothmuscle contraction, and cell volume. This gene encodes a member ofthe potassium voltage-gated channel subfamily V. This member isidentified as a 'silent subunit', and it does not formhomomultimers, but forms heteromultimers with several othersubfamily members. Through obligatory heteromerization, it exerts afunction-altering effect on other potassium channel subunits. Thisprotein is strongly expressed in pancreas and has a weakerexpression in several other tissues.
References
Robson, A.G., et al. Retina (Philadelphia, Pa.) 30(1):51-62(2010)Ben Salah, S., et al. Am. J. Ophthalmol. 145(6):1099-1106(2008)Wissinger, B., et al. Invest. Ophthalmol. Vis. Sci. 49(2):751-757(2008)Thiagalingam, S., et al. Ophthalmic Genet. 28(3):135-142(2007)Balijepalli, R.C., et al. Channels (Austin) 1(4):263-272(2007)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.